Stockscreener 앱 받기
2.50
14.16%
0.31
시간 외 거래:
2.53
0.03
+1.20%
전일 마감가:
$2.19
열려 있는:
$2.3
하루 거래량:
1.11M
Relative Volume:
2.82
시가총액:
$215.00M
수익:
$25.14M
순이익/손실:
$-21.57M
주가수익비율:
-9.2593
EPS:
-0.27
순현금흐름:
$-12.23M
1주 성능:
+12.61%
1개월 성능:
+14.16%
6개월 성능:
+2.88%
1년 성능:
+35.14%
1일 변동 폭
$2.29
$2.565
1주일 범위
$2.18
$2.565
52주 변동 폭
$1.54
$2.7155
Stereotaxis Inc Stock (STXS) Company Profile
명칭
Stereotaxis Inc
전화
314-678-6100
주소
4320 Forest Park Avenue, Suite 100, St. Louis, MO
STXS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.50 | 203.06M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
470.08 | 169.94B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
193.50 | 49.41B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
283.90 | 41.12B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
85.75 | 41.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
240.98 | 17.06B | 2.90B | 467.20M | 306.90M | 6.37 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-01-10 | 개시 | ROTH MKM | Buy |
| 2022-07-12 | 개시 | Aegis Capital | Buy |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2022-01-05 | 개시 | Craig Hallum | Buy |
| 2022-01-05 | 개시 | Loop Capital | Buy |
| 2021-05-26 | 개시 | Piper Sandler | Overweight |
| 2020-09-08 | 개시 | Northland Capital | Outperform |
| 2020-04-09 | 개시 | Cowen | Outperform |
| 2020-04-07 | 개시 | Lake Street | Buy |
모두보기
Stereotaxis Inc 주식(STXS)의 최신 뉴스
Stereotaxis: Pioneering the Future of Robotic Cardiology Amid Strategic Momentum - AInvest
Does Stereotaxis Inc. show high probability of reboundFree Weekly Watchlist of High Movers - Newser
Stereotaxis reiterates double-digit revenue growth outlook for 2025 as new catheter launches drive commercial momentum - MSN
Forecasting Stereotaxis Inc. price range with options dataFree Day Trading Signals With High Precision - Newser
Intraday pattern recognizer results for Stereotaxis Inc.Strong Buy Signal Summary with Entry Zone - Newser
Historical volatility pattern of Stereotaxis Inc. visualizedFree Daily Smart Money Movement Monitor - Newser
Regression analysis insights on Stereotaxis Inc. performanceFree Triple Digit Growth Focused Trade Plan - Newser
What makes Stereotaxis Inc. stock price move sharplyBuy and Hold Position Summary Review - Newser
Should I buy Stereotaxis Inc. stock before earningsFree Weekly Setup With 3x Return Potential - Newser
Stereotaxis Reports Double-Digit Revenue Growth for 2025 Amidst New Catheter Launches - AInvest
Stereotaxis (STXS): A Robotics-Driven Inflection Point in 2025 - AInvest
Is Stereotaxis Inc. a Top Dividend Stock to Watch in 2025Buy Candidate Summary Based on Fundamentals - Newser
Earnings call transcript: Stereotaxis Q2 2025 revenue beats forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: Stereotaxis Q2 2025 revenue beats forecasts - Investing.com
Best data tools to analyze Stereotaxis Inc. stockFree Weekly Hot Picks With Buy Confidence - Newser
Stereotaxis Inc. recovery potential after sell offLow Risk Trade Timing with Analysis Metrics - Newser
Stereotaxis Q2 2025 Earnings: Revenue Surges to $8.8 Million, EPS of -$0.05 Beats Estimates. - AInvest
Stereotaxis Inc (STXS) Q2 2025 Earnings Call Highlights: Impressive Revenue Surge and Strategic Advancements - GuruFocus
Stereotaxis reports Q2 EPS (5c), consensus (6c) - TipRanks
Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Stereotaxis earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Unlocking Value in Stereotaxis: A High-Growth Medical Tech Play in a Resilient Sector - AInvest
Stereotaxis Reports 2025 Second Quarter Financial Results - GlobeNewswire
Stereotaxis Reports Massive 95% Revenue Jump as New FDA-Cleared Robotic Catheter Drives Growth - Stock Titan
Will Stereotaxis Inc. see short term momentumAI Generated Momentum Stock Forecast Guide - Newser
Does Stereotaxis Inc. stock perform well during market downturnsUnbelievable profit margins - Jammu Links News
What drives Stereotaxis Inc. stock pricePhenomenal returns - Jammu Links News
How strong is Stereotaxis Inc. company’s balance sheetAccelerated investment success - Jammu Links News
What are analysts’ price targets for Stereotaxis Inc. in the next 12 monthsUnprecedented profit potential - Jammu Links News
Should I hold or sell Stereotaxis Inc. stock in 2025Maximize returns with disciplined trading - Jammu Links News
How does Stereotaxis Inc. compare to its industry peersInvest confidently with proven investment plans - Jammu Links News
Stereotaxis Inc. Stock Analysis and ForecastDynamic profit expansion - Jammu Links News
What is Stereotaxis Inc. company’s growth strategyRapidly growing investment returns - Jammu Links News
Is Stereotaxis Inc. a growth stock or a value stockMaximize returns with strategic stock selection - Jammu Links News
What institutional investors are buying Stereotaxis Inc. stockFree Buy/Sell Signal Notifications - Jammu Links News
Trendlines Suggest Stereotaxis Inc. May Bottom Out SoonAccurate Buy Point for Momentum Stocks Detected - metal.it
Stereotaxis Inc.’s volatility index tracking explainedFree Reliable Alerts for Daily Stock Movers - Newser
What are Stereotaxis Inc. company’s key revenue driversAI Powered Growth Plan For 2025 - Jammu Links News
Monogram robot marks autonomy milestone; Stereotaxis catheter cleared - MedTech Dive
Stereotaxis Inc. Q2 Earnings Preview: Revenue Up 76.7%, EPS Unchanged - AInvest
Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Is Stereotaxis Inc. stock bottoming outReliable Alerts for Daily Stock Movers Released - metal.it
Why did STXS revenue surge in Q3 2024 despite rising expenses? - AInvest
How does Stereotaxis Inc. generate profit in a changing economySwing Trade Entry Points For Fast Growth - jammulinksnews.com
Navigating STXS’s Stock Market Maze: Ups and Downs in 2025 - investchronicle.com
Stereotaxis' MAGiC Sweep: A Strategic Inflection Point in Robotic Electrophysiology - AInvest
Stereotaxis wins FDA clearance for diagnostic mapping catheter - Yahoo Finance
Stereotaxis' FDA-Cleared MAGiC Sweep Catheter: A Catalyst for Growth in the Robotic Ablation Era - AInvest
Stereotaxis Wins FDA Nod for MAGiC Sweep EP Catheter - Medical Product Outsourcing
Stereotaxis stock soars after FDA clearance for robotic mapping catheter By Investing.com - Investing.com Canada
Stereotaxis receives FDA clearance for robotic mapping catheter By Investing.com - Investing.com Nigeria
Stereotaxis Inc (STXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
자본화:
|
볼륨(24시간):